Aquilo Capital Management, LLC Regenxbio Inc. Transaction History

Aquilo Capital Management, LLC

$51.3 Million
Q1 2025

A detailed history of Aquilo Capital Management, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 271,302 shares of RGNX stock, worth $2.32 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares

271,302

Previous 346,302 21.66%

Holding current value

$2.32 Million

Previous $2.68 Million 27.54%

% of portfolio

3.78%

Previous 4.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$5.92 - $8.7 $444,000 - $652,500	-75,000 Reduced 21.66%	271,302 $1.94 Million
Q4 2024 Feb 14, 2025	SELL	$7.23 - $11.56 $4.23 Million - $6.76 Million	-584,406 Reduced 62.79%	346,302 $2.68 Million
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $256,585 - $351,979	24,460 Added 2.7%	930,708 $9.76 Million
Q1 2024 May 15, 2024	BUY	$12.17 - $24.61 $1.26 Million - $2.56 Million	103,824 Added 12.94%	906,248 $19.1 Million
Q4 2023 Feb 14, 2024	SELL	$12.89 - $20.82 $580,050 - $936,900	-45,000 Reduced 5.31%	802,424 $14.4 Million
Q3 2023 Nov 14, 2023	SELL	$16.46 - $19.99 $373,477 - $453,573	-22,690 Reduced 2.61%	847,424 $13.9 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $673,693 - $848,861	39,100 Added 4.71%	870,114 $17.4 Million
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $1.21 Million - $1.64 Million	-66,670 Reduced 7.43%	831,014 $15.7 Million
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $1.43 Million - $1.73 Million	-70,000 Reduced 7.23%	897,684 $20.4 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $4.46 Million - $7.01 Million	-200,000 Reduced 17.13%	967,684 $25.6 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $948,150 - $1.72 Million	49,000 Added 4.38%	1,167,684 $28.8 Million
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $2.59 Million - $3.61 Million	105,088 Added 10.37%	1,118,684 $37.1 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $5.27 Million - $7.03 Million	174,457 Added 20.79%	1,013,596 $33.1 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $7.09 Million - $11.1 Million	243,695 Added 40.93%	839,139 $35.2 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $1.17 Million - $1.46 Million	36,000 Added 6.43%	595,444 $23.1 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $1.88 Million - $2.8 Million	56,000 Added 11.12%	559,444 $19.1 Million
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $194,020 - $361,044	-7,316 Reduced 1.43%	503,444 $22.8 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $1.15 Million - $1.72 Million	-42,693 Reduced 7.71%	510,760 $14.1 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $7.78 Million - $12.2 Million	280,242 Added 102.57%	553,453 $20.4 Million
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $95,309 - $240,268	4,433 Added 1.65%	273,211 $8.85 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $9.28 Million - $12.1 Million	268,778 New	268,778 $11 Million

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.4M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $370M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Account

Aquilo Capital Management, LLC Regenxbio Inc. Transaction History